CardiOx Corp Closes $8M Series C Funding Round – Sets the Stage for U.S. and European Commercialization and Distribution

Upper Arlington-based CardiOx Corp has announced the closing of an $8 million Series C funding round.  Investments will support the company, which is developing a noninvasive device for detecting right-to-left heart shunts, through commercialization in the U.S. and Europe. 

CardiOx has previously raised $4 million in venture and angel funding in two rounds, along with another $1 million in grants from the Ohio Third Frontier.  Reservoir Venture Partners led the Series A funding, with co-investments from the TechColumbus Pre-Seed Fund in 2009.   Additional Series A investors included the Co-Investment Fund, Early Stage Partners, Ohio TechAngels, Northcoast Angels, Glengary LLC and individual angel investors.

For more details on the latest developments and funding, see the story as reported in MedCity News.